SME Times is powered by   
Search News
Just in:   • India's industrial production registers 1.2 per cent growth in May  • Govt committed to building safe and smart energy future: Minister  • Sanchez defends Spain's defence budget in response to Trump's threats  • Iran says no agreement made to resume US talks  • India’s engineering goods exports to US rose 4.6 pc in May despite tariff turmoil 
Last updated: 27 Jun, 2017  

Lupin THMB Lupin founder Gupta passes away in Mumbai

lupin.jpg
   Top Stories
» India's industrial production registers 1.2 per cent growth in May
» Govt committed to building safe and smart energy future: Minister
» QCOs benefit MSMEs by enhancing product quality, consumer satisfaction: Piyush Goyal
» Stock market opens higher as Trump indicates ‘great’ trade deal with India
» Make GIFT IFSC more competitive to attract foreign investments: FM Sitharaman
SME Times News Bureau | 27 Jun, 2017
Drug maker Lupin's founder and Chairman Desh Bandhu Gupta passed away here on Monday. He was 79.

"We are deeply saddened with the demise of our father (Gupta) on early Monday. What he had put in motion 50 years ago in helping to create, innovate and lead in the pharmaceutical space is an unparalleled legacy," said Lupin Chief Executive Nilesh Gupta in a statement in Mumbai.

Born in 1938 at Rajgarh in Rajasthan, Gupta had a Master of Science (M.Sc) degree in Chemistry and a vision to fight life-threatening diseases of national priority by delivering quality medicines at affordable price.

"Those who knew and worked with Gupta, remember him for his generosity and for fostering a dynamic environment where people could learn and grow. We will continue to build on his legacy and live by the values he instilled," asserted his son Nilesh.

After moving to Mumbai in the mid-60s, Gupta founded Lupin in 1968 and has been a pioneer in the country's pharmaceutical landscape.

Gupta will be remembered as a visionary, path-breaker and a nationalist who created a strong legacy of a global pharmaceutical major with presence in over 100 countries.

"It was under Gupta's leadership that the company grew to a global pharmaceutical major from being a domestic drug firm," said the statement, adding that the company was the world's fourth largest generics pharma player by market capitalisation.

A firm believer in the concept of holistic development, Gupta had also set-up Lupin Human Welfare and Research Foundation in 1988 to eradicate poverty by encouraging sustainable development at the grass root level in rural India.

"Gupta's efforts led to a positive impact on the lives of 2.8 million families in 3,463 villages across the country," added the statement.

The company posted consolidated sales of Rs 17,120 crore ($2.55 billion) and net profit of Rs 2,558 crore ($381 million) for the last fiscal (2016-17).

The drug major is a significant player in the cardiovascular, diabetology, asthma, paediatric and other areas and holds leadership position in the anti-TB segment.
 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
84.35
82.60
UK Pound
106.35
102.90
Euro
92.50
89.35
Japanese Yen 55.05 53.40
As on 12 Oct, 2024
  Daily Poll
Do you think Indian businesses will be negatively affected by Trump's America First Policy?
 Yes
 No
 Can't Say
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter